Midkine

Midkine Overview

English Name	Midkine	Approved Drugs	0
Drugs in Clinical Trials	1	Target Synonym	Midkine，Midgestation and kidney protein，Neurite outgrowth-promoting factor 2，Neurite outgrowth-promoting protein，Amphiregulin-associated protein，NEGF2，ARAP，FLJ27379，Neurite Growth-Promoting Factor 2，Retinoic Acid Inducible Factor，MK1，MDK，MK
Highest Development Stage	Clinical

English Name	Midkine
Target Synonym	Midkine，Midgestation and kidney protein，Neurite outgrowth-promoting factor 2，Neurite outgrowth-promoting protein，Amphiregulin-associated protein，NEGF2，ARAP，FLJ27379，Neurite Growth-Promoting Factor 2，Retinoic Acid Inducible Factor，MK1，MDK，MK
Approved Drugs	0
Drugs in Clinical Trials	1
Highest Development Stage	Clinical

Midkine Product List

Product Category
Protein (1)
Product Status
Launched (1)
Species
Human (1)
Tag
Tag Free (1)
Conjugate
Unconjugated (1)

Cat. No.	Species	Host	Product Description	Structure	Purity	Feature	Order Now
MIE-H5117	Human	E. coli	Human Midkine / Mdk Protein, premium grade				Add to Cart

Total: 1

Midkine Background

Midkine (MK or MDK), also known as neurite growth-promoting factor 2 (NEGF2), is a protein that in humans is encoded by the MDK gene. Midkine is a basic heparin-binding growth factor of low molecular weight, and forms a family with pleiotrophin (NEGF1, 46% homologous with MK). It is a nonglycosylated protein, composed of two domains held by disulfide bridges. It is a developmentally important retinoic acid-responsive gene product strongly induced during mid-gestation, hence the name midkine. Restricted mainly to certain tissues in the normal adult, it is strongly induced during oncogenesis, inflammation and tissue repair.